Only Medics London office move to Bouverie Street On Friday May 24th, our London office will be moving from its current location in its offices in Quantum House, to 11-12 Bouverie Street. This move will more than double the office space from 700sq ft, to a new much bigger environment of 1,600sq ft – a
Icon continued their run of solid quarterly results, reporting an operating income of US $23.0 million, an increase of 96.0% year on year. Net revenues were also higher, at US $316.8 million. The income total included reorganisation, and other items amounting to US $4.41 million. Without these charges operating income was up to US $27.4
Elan Corp have confirmed that they have declined Royalty Pharma’s $11.25 per share acquisition bid, adding that the bid does not come near to what the drug maker is worth. Last week, Royalty decreased their bid from a previous offer which could have reached as high as $12, depending upon the pricing of a $1
Royalty Pharma have increased their bid to acquire Elan Corp, in a move that values the Irish drug maker to up to $7.30 billion. After being asked by the Irish Takeover Panel to make a tangible offer by May 10th or abandon their plans to buy Elan, Royalty has made what they describe as a
Do you earn the correct amount? As part of the Clinical Professionals Group, Only Medics are launching a European salary survey to determine the salary and benefits for European pharmaceutical physicians. The salary survey consists of questions concerning your career and how satisfied you are with your current salary, and will only take a few minutes to
AstraZeneca have today announced that they are expanding their cardiovascular and metabolic disease pipeline with the acquisition of AlphaCore Pharma. AlphaCore are a Michigan-based biotechnology company focused on the development of ACP-501, a recombinant human lecithin-cholesterol acyltransferase (LCAT) enzyme. AstraZeneca’s MedImmune unit is buying privately-held AlphaCore primarily because of ACP-501. AstraZeneca note that LCAT is
Cancer Research Technology (CRT) and the Institute of Cancer Research (ICR) announced earlier today that they have partnered with Johnson & Johnson unit, Janssen Biotech, in an agreement to discover a potential new drug for the blood cancer, multiple myeloma. The partnership is aiming to identify molecules and develop them into experimental therapies that block
Prices of medicines should be lower and the high cost of research is a myth, according to GlaxoSmithKline’s boss Sir Andrew Witty. The pharmaceutical industry should be able to charge less for new drugs in the future by passing on efficiencies within R&D to their customers, according to the chief executive of GSK. High prices
Only Medics will be attending DGPharMed’s annual conference at the Hotel Concorde, Berlin, Germany on the 14th and 15th March 2012. 2013 sees the 29th year of the annual conference by the German Society of Pharmaceutical Medicine. The conference starts at 9:20am, and finishes the following day. The topic of this year’s conference will be
As part of our continued expansion, Only Medics have relocated to a new larger UK office, having outgrown our previous office. The new office is over double the size of the previous UK office, allowing Only Medics to continue growing to fit your future needs. Our new office is located at: 1st Floor 33 Blagrave
